11月 2025
- 首頁
- GARDP
11月 2025GARDP的市場佔有率分析
Central to GARDP’s work is a team of individuals who are dedicated to the organization’s mission and share its values of people-centredness, integrity, teamwork
GARDP(包含公司地區)
查看更多網站流量與參與度資訊- gardp.org
GARDP的熱門網域總造訪量
了解GARDP市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
GARDP的熱門網域平均造訪時長
分析GARDP參與度指標。
過去 3 個月平均造訪時長
子公司細目
GARDP的熱門網域平均頁面瀏覽量
了解GARDP如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自GARDP
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Global Antibiotic Research and Development Partnership partners with Innoviva Specialty Therapeutics, Inc..The nonprofit Global Antibiotic Research and Development Partnership collaborated with Innoviva Specialty Therapeutics Inc. to develop the drug.
12月 15, 2025閱讀更多
新聞Innoviva, Inc partnered with Global Antibiotic Research and Development Partnership on Jun 10th '25.Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for zoliflodacin, the investigational first-in-class, single dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.
6月 10, 2025閱讀更多
新聞Global Antibiotic Research and Development Partnership hired Prof Gray as Chair on Feb 19th '25.Prof Gray was recently appointed as the Chair of GARDP, a Geneva-based not-for-profit organisation dedicated to addressing the global crisis of antimicrobial resistance (AMR).
3月 19, 2025閱讀更多
查看所有GARDP信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。